TELA Bio, Inc. (TELA)
NASDAQ·Healthcare·Medical - Devices
$0.78
-2.83%
Mkt Cap $39.41M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $21.03M | $20.87M | -0.79% | -$0.18 | -$0.16 | +11.11% | — | — |
| Q4 2025 Nov 13, 2025 | $21.04M | $20.69M | -1.67% | -$0.17 | -$0.19 | -11.76% | — | — |
| Q3 2025 Aug 11, 2025 | $22.14M | $20.20M | -8.79% | -$0.18 | -$0.22 | -22.22% | — | — |
| Q2 2025 May 8, 2025 | $17.35M | $18.52M | +6.73% | -$0.21 | -$0.25 | -19.05% | — | — |
| Q1 2025 Mar 20, 2025 | $21.05M | $17.65M | -16.15% | -$0.24 | -$0.23 | +4.17% | — | — |
| Q4 2024 Nov 7, 2024 | $23.17M | $18.96M | -18.17% | -$0.37 | -$0.42 | -13.51% | — | — |
| Q3 2024 Aug 12, 2024 | $18.46M | $16.09M | -12.83% | -$0.45 | -$0.51 | -13.33% | — | — |
| Q2 2024 May 9, 2024 | $16.32M | $16.60M | +1.73% | -$0.48 | -$0.23 | +52.08% | — | — |
| Q1 2024 Mar 21, 2024 | $16.39M | $17.00M | +3.71% | -$0.44 | -$0.53 | -20.45% | — | — |
| Q4 2023 Nov 9, 2023 | $16.39M | $15.05M | -8.16% | -$0.52 | -$0.45 | +13.46% | — | — |
| Q3 2023 Aug 9, 2023 | $14.40M | $14.49M | +0.65% | -$0.58 | -$0.46 | +20.69% | — | — |
| Q2 2023 May 11, 2023 | $12.02M | $11.91M | -0.92% | -$0.51 | -$0.63 | -23.53% | — | — |
| Q1 2023 Mar 21, 2023 | $13.19M | $11.62M | -11.89% | -$0.58 | -$0.52 | +10.34% | — | — |
| Q4 2022 Nov 9, 2022 | $10.86M | $11.16M | +2.74% | -$0.57 | -$0.64 | -12.28% | — | — |
| Q3 2022 Aug 10, 2022 | $10.12M | $10.41M | +2.81% | -$0.60 | -$0.80 | -33.33% | — | — |
| Q2 2022 May 10, 2022 | $7.94M | $8.23M | +3.62% | -$0.50 | -$0.75 | -50.00% | — | — |
| Q1 2022 Mar 21, 2022 | $7.97M | $8.37M | +5.13% | -$0.54 | -$0.59 | -9.26% | — | — |
| Q4 2021 Nov 10, 2021 | $6.92M | $7.65M | +10.64% | -$0.52 | -$0.57 | -9.62% | — | — |
| Q3 2021 Aug 11, 2021 | $6.31M | $7.56M | +19.78% | -$0.49 | -$0.57 | -16.33% | — | — |
| Q2 2021 May 13, 2021 | $5.46M | $5.88M | +7.64% | -$0.44 | -$0.56 | -27.27% | — | — |